The cancellation part of the news, which we heard last week, was not good news. But this is a newer article, clarifying, somewhat I think, what happened last week.
What I thought was good news, is the fact that it mentions what has to be done to get approval from the KSA FDA. (Keep in mind that these translations are rough.) "...explain its characteristics, so that the necessary FDA requirements are met, to confirm the effectiveness and safety of the device, and the purpose-made for him."
Given all the data and trials of the AS process--coupled with the fact that MERS is a huge problem in SA--I would tend to think that the powers that be over there will work quickly toward regulatory approval.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.